SCHEMBL25720287

SCHEMBL25720287

Oc1cc(-c2ccccc2)nn1-c1nc(N2CCOCC2)c2cccnc2n1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 12/20 0.57
MTOR P42345 11/20 0.57
PIK3CD O00329 3/20 0.57
PIK3CG P48736 2/20 0.57
PIK3R1 P27986 6/20 0.49
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
METAP1 P53582 1/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
PIK3C2A O00443 1/20 0.43
PIK3C2B O00750 1/20 0.43
PRKDC P78527 1/20 0.43
PIK3C3 Q8NEB9 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25270780 0.84 PIK3CA (0.57) PIK3CAMTORPIK3CDPIK3CGPIK3R1
SCHEMBL258487 0.76 PIK3CA (0.74) PIK3CAMTORPIK3CDPIK3CGPIK3R1
SCHEMBL25720286 0.74 PIK3CA (0.55) PIK3CAMTORPIK3CDPIK3CGALDH1A1
SCHEMBL30986787 0.74 PIK3CA (0.55) PIK3CAMTORPIK3CDPIK3CGALDH1A1
SCHEMBL25228692 0.72 PIK3CA (0.52) PIK3CAMTORPIK3CDPIK3CGPIK3R1
SCHEMBL30308924 0.72 PIK3CA (0.54) PIK3CAMTORPIK3CDPIK3CGPIK3R1
SCHEMBL25232064 0.71 KDM4E (0.49) PIK3CAPIK3CGALOX15ALDH1A1KDM4E
SCHEMBL9293847 0.71 MAPT (0.45) ALOX15MAPK1ALDH1A1KDM4EHPGD
SCHEMBL25735294 0.70 ALDH1A1 (0.36) PIK3CAMTORPIK3CGPIK3R1ALDH1A1
SCHEMBL16094600 0.69 PIK3CA (0.60) PIK3CAMTORPIK3CDPIK3CGPIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208964-A1 PYRIDOPYRIMIDINES AND METHODS OF THEIR USE YUMANITY THERAPEUTICS, INC. 2024-06-27 US disclosed
US-20240208964-A1 PYRIDOPYRIMIDINES AND METHODS OF THEIR USE YUMANITY THERAPEUTICS, INC. 2024-06-27 US disclosed
WO-2023107592-A1 PYRIDOPYRIMIDINES AND METHODS OF THEIR USE Kineta, Inc. (US) 2023-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208964-A1 PYRIDOPYRIMIDINES AND METHODS OF THEIR USE PNPO, DPYD, PYGB PIK3CA 3369/4885MTOR 4255/4885PIK3CD 3769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.